咖啡消费与心脏代谢健康:证据的综合评价。
Coffee consumption and cardiometabolic health: a comprehensive review of the evidence.
机构信息
Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.
出版信息
Geroscience. 2024 Dec;46(6):6473-6510. doi: 10.1007/s11357-024-01262-5. Epub 2024 Jul 4.
This review provides a comprehensive synthesis of longitudinal observational and interventional studies on the cardiometabolic effects of coffee consumption. It explores biological mechanisms, and clinical and policy implications, and highlights gaps in the evidence while suggesting future research directions. It also reviews evidence on the causal relationships between coffee consumption and cardiometabolic outcomes from Mendelian randomization (MR) studies. Findings indicate that while coffee may cause short-term increases in blood pressure, it does not contribute to long-term hypertension risk. There is limited evidence indicating that coffee intake might reduce the risk of metabolic syndrome and non-alcoholic fatty liver disease. Furthermore, coffee consumption is consistently linked with reduced risks of type 2 diabetes (T2D) and chronic kidney disease (CKD), showing dose-response relationships. The relationship between coffee and cardiovascular disease is complex, showing potential stroke prevention benefits but ambiguous effects on coronary heart disease. Moderate coffee consumption, typically ranging from 1 to 5 cups per day, is linked to a reduced risk of heart failure, while its impact on atrial fibrillation remains inconclusive. Furthermore, coffee consumption is associated with a lower risk of all-cause mortality, following a U-shaped pattern, with the largest risk reduction observed at moderate consumption levels. Except for T2D and CKD, MR studies do not robustly support a causal link between coffee consumption and adverse cardiometabolic outcomes. The potential beneficial effects of coffee on cardiometabolic health are consistent across age, sex, geographical regions, and coffee subtypes and are multi-dimensional, involving antioxidative, anti-inflammatory, lipid-modulating, insulin-sensitizing, and thermogenic effects. Based on its beneficial effects on cardiometabolic health and fundamental biological processes involved in aging, moderate coffee consumption has the potential to contribute to extending the healthspan and increasing longevity. The findings underscore the need for future research to understand the underlying mechanisms and refine health recommendations regarding coffee consumption.
这篇综述综合了关于咖啡消费对心血管代谢影响的纵向观察性和干预性研究,探讨了生物学机制以及临床和政策意义,突出了证据中的空白,并提出了未来的研究方向。还回顾了基于孟德尔随机化(MR)研究的咖啡消费与心血管代谢结局之间因果关系的证据。研究结果表明,虽然咖啡可能会导致血压短期升高,但不会增加长期高血压风险。有有限的证据表明,咖啡摄入可能降低代谢综合征和非酒精性脂肪肝的风险。此外,咖啡消费与 2 型糖尿病(T2D)和慢性肾脏病(CKD)风险降低呈一致相关,具有剂量反应关系。咖啡与心血管疾病的关系复杂,显示出潜在的预防中风益处,但对冠心病的影响不明确。适量饮用咖啡(通常每天 1 至 5 杯)与心力衰竭风险降低有关,而其对心房颤动的影响尚无定论。此外,咖啡消费与全因死亡率呈倒 U 型相关,适度饮用水平观察到的风险降低最大。除 T2D 和 CKD 外,MR 研究并未强有力地支持咖啡消费与不良心血管代谢结局之间的因果关系。咖啡对心血管代谢健康的潜在有益影响在年龄、性别、地理位置和咖啡类型上具有一致性,涉及抗氧化、抗炎、调脂、胰岛素敏化和产热作用等多个方面。基于其对心血管代谢健康的有益影响以及与衰老相关的基本生物学过程,适量饮用咖啡有可能延长健康寿命并增加寿命。这些发现强调了未来研究的必要性,以了解潜在机制并完善关于咖啡消费的健康建议。